Renal metastases from thyroid papillary carcinoma: Study of sodium iodide symporter expression

Thyroid

Volumn 11, Issue 8, 2001, Pages 795-804

  Smallridge, R C ^a   Castro, M R ^b   Morris, J C ^b   Young, P R ^a   Reynolds, J C ^c   Merino, M J ^d   Sarlis, N J ^e  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; IODINE 131; KI 67 ANTIGEN; PROTEIN; PROTEIN P53; SODIUM IODIDE SYMPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASPIRATION BIOPSY; BONE METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; KIDNEY METASTASIS; LUNG METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

EID: 0034881056     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250152484664     Document Type: Article

References (58)

1. Tumors of the kidney, renal pelvis, and ureter
2. Secondary carcinomas of the kidney
3. Thyroid carcinoma and death: A clinicopathological study of 193 autopsies
4. Thyroid cancer: A study of 573 thyroid tumors and 161 autopsy cases observed over a thirty-year period
5. A comparison of the effectiveness of 131-I whole body scans and plasma Tg determinations in the diagnosis of metastatic differentiated carcinoma of the thyroid: A retrospective study
6. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma
7. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
8. Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus Tg levels after hormone withdrawal and total body scan: Results in 291 patients with thyroid cancer
9. Low iodine diet in I-131 ablation of thyroid remnants
10. A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer
11. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer
12. Lithium as a potential adjuvant to 131-I therapy of metastatic, well differentiated thyroid carcinoma
13. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: Relationship to serum thyrotropin levels
14. Elecsys thyrotropin (TSH) assay evaluated
15. Current status and performance goals for serum thyroglobulin assays
16. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii
17. Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome
18. Two simple methods for measuring iodine in urine
19. Validation of a simple, manual urinary iodine method for estimating the prevalence of iodine-deficiency disorders, and interlaboratory comparison with other methods
20. Development of monoclonal antibodies against the human sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells
21. Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer
22. Proliferation markers
23. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarmin-fixed, embedded tissue
24. Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens
25. The histological spectrum of hemangiopericytoma: Application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis
26. Distant metastases in papillary thyroid carcinoma: 100 Cases observed at one institution during 5 decades
27. A case of bilateral metastatic renal tumor originating from a thyroid carcinoma
28. Renal metastases from well differentiated follicular thyroid carcinoma: A case report with light and electron microscopic findings
29. Renal metastasis of a metastasizing thyroid adenoma
30. Follicular carcinoma of the thyroid metastatic to the kidney 37 years after resection of the primary tumor
31. Metastasis of thyroid carcinoma. A rare case of secondary renal tumor
32. Renal metastases from papillary thyroid carcinoma
33. Resection of metastatic thyroid carcinomas to the liver and the kidney: Report of a case
34. Metastatic papillary thyroid carcinoma presenting as a primary renal neoplasm
35. Renal metastasis from thyroid carcinoma visible as a hyperdense lesion on unenhanced CT
36. Cloning and characterization of the thyroid iodide transporter
37. Cloning of the human sodium-iodide symporter
38. - symporter distribution in human thyroid tissues: An immunohistochemical study
39. - symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes
40. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas
41. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells
42. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology
43. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis
44. False-positive scans in papillary thyroid carcinoma
45. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples
46. False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst
47. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy
48. Post-therapy iodine-131 localization in unsuspected large renal cyst: Possible mechanisms
49. Uptake of I-131 in the biliary tract: A potential cause of a false-positive result of scintiscan
50. Occult distant metastases of well-differentiated thyroid carcinoma
51. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide messenger ribonucleic acid and protein
52. i67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
53. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas
54. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland
55. Surgical treatment of distant metastases in differentiated thyroid cancer: Indication and results
56. The role of extensive metastatectomy in the long-term management of clinically aggressive thyroid carcinoma. The NIH experience
57. The changing role of radioiodine in the management of differentiated thyroid cancer
58. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer